• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Adaptive Biotechnologies Corporation - Common Stock (NQ:ADPT)

    12.77 +0.36 (+2.90%)
    Streaming Delayed Price Updated: 2:03 PM EDT, Mar 30, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 835,381
    Open 12.45
    Bid (Size) 12.76 (300)
    Ask (Size) 12.78 (700)
    Prev. Close 12.41
    Today's Range 12.27 - 13.02
    52wk Range 6.675 - 20.76
    Shares Outstanding 144,311,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Adaptive Biotech Insider Sale of 180,000 Shares Tied to Tax Event as Stock Jumps 70% in a Year ↗
    Adaptive Biotechnologies, a leader in immune-driven diagnostics, saw a notable insider sale amid ongoing innovation in disease monitoring. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Adaptive Biotechnologies Insider Sells $1 Million in Stock After a Doubling in Share Price ↗
    Adaptive Biotechnologies, a leader in immune-driven diagnostics, reported a notable insider sale after a strong one-year stock performance. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    -19.7%
    -19.7%
    1 Month
    -20.3%
    -20.3%
    3 Month
    -23.3%
    -23.3%
    6 Month
    -5.1%
    -5.1%
    1 Year
    +71.9%
    +71.9%

    More News

    Read More
    News headline image
    Adaptive Biotech (ADPT) Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    Adaptive Biotechnologies (NASDAQ:ADPT) Reports Strong Q4 Revenue Beat and Path to Profitability ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For November 5, 2025 ↗
    Via Benzinga
    News headline image
    Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results
    From Adaptive Biotechnologies
    Via GlobeNewswire
    News headline image
    Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
    From Adaptive Biotechnologies
    Via GlobeNewswire
    News headline image
    Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
    From Adaptive Biotechnologies
    Via GlobeNewswire
    News headline image
    Adaptive Biotechnologies Surges as Preliminary 2025 Results Signal a Turning Point in MRD Commercialization
    Via MarketMinute
    News headline image
    Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results
    From Adaptive Biotechnologies
    Via GlobeNewswire
    News headline image
    The Year-End Biotech Chill: Adaptive Biotechnologies Braces for J.P. Morgan Crucible Amid Market Sell-Off
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From Adaptive Biotechnologies
    Via GlobeNewswire
    News headline image
    Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer
    From Adaptive Biotechnologies
    Via GlobeNewswire
    News headline image
    Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease
    From Adaptive Biotechnologies
    Via GlobeNewswire
    News headline image
    Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting
    From Adaptive Biotechnologies
    Via GlobeNewswire
    News headline image
    Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting
    From Adaptive Biotechnologies
    Via GlobeNewswire
    News headline image
    Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
    From Adaptive Biotechnologies
    Via GlobeNewswire
    News headline image
    Adaptive Biotechnologies Reports Third Quarter 2025 Financial Results
    From Adaptive Biotechnologies
    Via GlobeNewswire
    News headline image
    Cathie Wood Goes All-In On Peter Thiel's Crypto Play Bullish With Back-To-Back Million-Dollar Buys ↗
    Via Benzinga
    News headline image
    Adaptive Biotechnologies to Report Third Quarter 2025 Financial Results on November 5, 2025
    From Adaptive Biotechnologies
    Via GlobeNewswire
    News headline image
    Tesla To $300? Here Are 10 Top Analyst Forecasts For Monday ↗
    Via Benzinga
    News headline image
    A Glimpse Into The Expert Outlook On Adaptive Biotechnologies Through 4 Analysts ↗
    Via Benzinga
    News headline image
    United Natural Foods Posts Upbeat Results, Joins AnaptysBio, Semtech, UiPath And Other Big Stocks Moving Higher On Tuesday ↗
    Via Benzinga
    News headline image
    Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
    From Adaptive Biotechnologies
    Via GlobeNewswire
    News headline image
    Adaptive Biotechnologies (NASDAQ:ADPT) Fits Minervini's Trend Template with Strong Growth Momentum ↗
    Via Chartmill

    Frequently Asked Questions

    Is Adaptive Biotechnologies Corporation - Common Stock publicly traded?
    Yes, Adaptive Biotechnologies Corporation - Common Stock is publicly traded.
    What exchange does Adaptive Biotechnologies Corporation - Common Stock trade on?
    Adaptive Biotechnologies Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Adaptive Biotechnologies Corporation - Common Stock?
    The ticker symbol for Adaptive Biotechnologies Corporation - Common Stock is ADPT on the Nasdaq Stock Market
    What is the current price of Adaptive Biotechnologies Corporation - Common Stock?
    The current price of Adaptive Biotechnologies Corporation - Common Stock is 12.77
    When was Adaptive Biotechnologies Corporation - Common Stock last traded?
    The last trade of Adaptive Biotechnologies Corporation - Common Stock was at 03/30/26 02:03 PM ET
    What is the market capitalization of Adaptive Biotechnologies Corporation - Common Stock?
    The market capitalization of Adaptive Biotechnologies Corporation - Common Stock is 1.84B
    How many shares of Adaptive Biotechnologies Corporation - Common Stock are outstanding?
    Adaptive Biotechnologies Corporation - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.